ArriVent BioPharma Reports First Quarter 2024 Financial Results
May 08, 2024 08:00 ET
|
ArriVent BioPharma, Inc.
Presented preclinical firmonertinib (formerly furmonertinib) data at the 2024 American Association for Cancer Research (“AACR”) Annual MeetingDosed first patient in Phase 1b combination study of...
Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
May 08, 2024 08:00 ET
|
Intra-Cellular Therapies Inc.
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central...
Intermex Reports First Quarter Results
May 08, 2024 08:00 ET
|
International Money Express, Inc.
Company generates strong earnings and margins, continued execution of omnichannel strategy Company to Host Conference Call Today at 9 a.m. ET MIAMI, May 08, 2024 (GLOBE NEWSWIRE) -- International...
Horizon Aircraft Provides Update on Technical Flight Testing Progress
May 08, 2024 08:00 ET
|
New Horizon Aircraft Ltd.
~ Continued Flight-Testing Progress Approaching Full Transition to Forward Flight of the Company’s Large-Scale Prototype eVTOL Aircraft ~ ~ Dynamic Video Footage of Most Recent Flight Test ~ ~...
authID Inc. Partners with IDMWORKS to Expand Reach of Its Biometric Identity Platform
May 08, 2024 08:00 ET
|
authID Inc.
authID to secure leading IAM provider’s workforce and customer identity clients across North America from malicious, generative AI-driven cyberattacks DENVER, May 08, 2024 (GLOBE...
Global Mofy Metaverse Pioneers the "Next Generation" of Content Creation with Gausspeed
May 08, 2024 08:00 ET
|
Global Mofy Metaverse Limited
Global Mofy Metaverse Pioneers the "Next Generation" of Content Creation with Gausspeed
Monster Beverage Corporation Commences Modified Dutch Auction Tender Offer to Purchase Up to $3.0 Billion of Its Outstanding Common Stock
May 08, 2024 08:00 ET
|
Monster Beverage Corporation
CORONA, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that it has commenced a modified “Dutch auction” tender offer to purchase shares of its...
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
May 08, 2024 08:00 ET
|
Belite Bio, Inc
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative...
Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 08, 2024 08:00 ET
|
Indaptus Therapeutics
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer...
60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial of Tafenoquine in Babesiosis in Letter to Journal of Infectious Diseases
May 08, 2024 07:59 ET
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharma plans clinical trial of Tafenoquine for Babesiosis. Letter to Journal of Infectious Diseases outlines protocol. Enrollment starts summer.